Literature DB >> 15958319

[Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy].

Ming-fei Chen1, Ru-cheng Li, Chang-hong Chen, Xiao-ci Gao.   

Abstract

OBJECTIVE: To observe the therapeutic effects of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy.
METHODS: Eighty-five patient with liver cirrhosis complicated by hepatic encephalopathy were divided into therapy group (n=45) and control group (n=40). Patients in the control group were treated with routine comprehensive therapy, and those in the therapy group received additional intravenous administration with 40 ml L-ornithine-L-aspartate in 250 ml 10% glucose and saline (once daily, 7 days for a treatment course).
RESULTS: L-ornithine-L-aspartase significantly decreased blood ammonia and improved hepatic function (P<0.05 or 0.01). The therapeutic effects of therapy group was better than that of the control group (P<0.05), and no significant side effect was observed in L-ornithine-L-aspartate treatment.
CONCLUSION: L-ornithine-L-aspartate is effective for hepatic encephalopathy and has not obvious side effect.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958319

Source DB:  PubMed          Journal:  Di Yi Jun Yi Da Xue Xue Bao        ISSN: 1000-2588


  5 in total

1.  L-Ornithine L-Aspartate is Effective and Safe for the Treatment of Hepatic Encephalopathy in Cirrhosis.

Authors:  Sandeep S Sidhu
Journal:  J Clin Exp Hepatol       Date:  2018-09-05

Review 2.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

3.  Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2019-07-23       Impact factor: 3.584

4.  Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Roger F Butterworth; Gerald Kircheis; Norbert Hilger; Mark J W McPhail
Journal:  J Clin Exp Hepatol       Date:  2018-05-22

Review 5.  L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Ee Teng Goh; Caroline S Stokes; Sandeep S Sidhu; Hendrik Vilstrup; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2018-05-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.